Chemoinformaics analysis of 2-Methyl-5-(8-pentadecenyl)-1,3-benzenediol
| Molecular Weight | 332.528 | nRot | 13 |
| Heavy Atom Molecular Weight | 296.24 | nRig | 7 |
| Exact Molecular Weight | 332.272 | nRing | 1 |
| Solubility: LogS | -2.966 | nHRing | 0 |
| Solubility: LogP | 7.095 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 62.3485 |
| nHD | 2 | BPOL | 36.1155 |
| QED | 0.307 |
| Synth | 2.374 |
| Natural Product Likeliness | 1.013 |
| NR-PPAR-gamma | 0.946 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.015 |
| CACO-2 | -4.869 |
| MDCK | 0.0000167 |
| BBB | 0.093 |
| PPB | 1.00004 |
| VDSS | 5.255 |
| FU | 0.00522322 |
| CYP1A2-inh | 0.479 |
| CYP1A2-sub | 0.386 |
| CYP2c19-inh | 0.703 |
| CYP2c19-sub | 0.087 |
| CYP2c9-inh | 0.217 |
| CYP2c9-sub | 0.972 |
| CYP2d6-inh | 0.911 |
| CYP2d6-sub | 0.902 |
| CYP3a4-inh | 0.438 |
| CYP3a4-sub | 0.103 |
| CL | 5.655 |
| T12 | 0.818 |
| hERG | 0.131 |
| Ames | 0.188 |
| ROA | 0.065 |
| SkinSen | 0.966 |
| Carcinogencity | 0.04 |
| EI | 0.977 |
| Respiratory | 0.778 |
| NR-Aromatase | 0.7 |
| Antiviral | Yes |
| Prediction | 0.626958 |